Aquestive Therapeutics, Inc. (AQST) Insider Trading -- Recent Executive & Director Transactions

13 insiders reported 71 Form 4 transactions for Aquestive Therapeutics, Inc. (AQST) over the past 18 months (most recent 2026-06-24). Recent activity: Krop Julie (Director) Buy 25,000 shares, Krop Julie (Director) Sell 25,000 shares, Barber Daniel (President and CEO) Sell 25,000 shares, Korczynski Sherry (Chief Commercial Officer) Sell 2,714 shares, Zalewski Thomas A. (Chief Legal Officer) Buy 100,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-24Krop JulieDirectorBuy25,000$17,830
2026-06-24Krop JulieDirectorSell25,000$125,392
2026-06-16Barber DanielPresident and CEOSell25,000$104,010
2026-06-09Korczynski SherryChief Commercial OfficerSell2,714$0
2026-05-19Zalewski Thomas A.Chief Legal OfficerBuy100,000$0
2026-05-18Barber DanielPresident and CEOSell8,257$35,413
2026-05-18Cioffi MelinaSVP, Regulatory AffairsSell1,667$6,951
2026-05-11BRAENDER LORI JCorporate SecretarySell135,690$573,969
2026-05-07Jung CassieChief Operating OfficerSell72,734$304,028
2026-05-07TOTH A ERNEST JRChief Financial OfficerSell92,652$387,285
2026-05-07Barber DanielPresident and CEOSell335,922$1.4M
2026-05-07BRAENDER LORI JCorporate SecretarySell76,147$318,294
2026-05-07Boyd Peter E.Chief People OfficerSell56,778$237,332
2026-03-11Cioffi MelinaSVP, Regulatory AffairsBuy100,000$0
2026-03-11BRAENDER LORI JChief Legal OfficerBuy80,000$0
2026-03-11BRAENDER LORI JChief Legal OfficerSell40,102$167,225
2026-03-11Boyd Peter E.Chief People OfficerBuy80,000$0
2026-03-11Boyd Peter E.Chief People OfficerSell29,814$124,324
2026-03-11Greenhawt Matthew J.Chief Medical OfficerBuy75,000$0
2026-03-11Barber DanielPresident and CEOBuy262,000$0
2026-03-11Barber DanielPresident and CEOSell180,677$753,423
2026-03-11Jung CassieChief Operating OfficerBuy80,000$0
2026-03-11Jung CassieChief Operating OfficerSell45,791$190,948
2026-03-11TOTH A ERNEST JRChief Financial OfficerBuy95,000$0
2026-03-11TOTH A ERNEST JRChief Financial OfficerSell58,254$242,919

Source: SEC Form 4 filings · as of 2026-06-24